Your browser doesn't support javascript.
loading
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats.
László, Szilvia B; Lázár, Bernadette; Brenner, Gábor B; Makkos, András; Balogh, Mihály; Al-Khrasani, Mahmoud; Hutka, Barbara; Mohammadzadeh, Amir; Kemény, Ágnes; László, Terézia; Scheich, Bálint; Szabados, Tamara; Kenyeres, Éva; Giricz, Zoltán; Bencsik, Péter; Varga, Zoltán V; Novák, Julianna; Helyes, Zsuzsanna; Ferdinandy, Péter; Gyires, Klára; Zádori, Zoltán S.
Afiliação
  • László SB; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Lázár B; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Brenner GB; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Makkos A; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Balogh M; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Al-Khrasani M; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Hutka B; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Mohammadzadeh A; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Kemény Á; Department of Medical Biology, University of Pécs, 7624 Pécs, Hungary; Department of Pharmacology and Pharmacotherapy, Medical School & Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
  • László T; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Scheich B; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Szabados T; Department of Pharmacology and Pharmacotherapy, University of Szeged, 6720 Szeged, Hungary.
  • Kenyeres É; Department of Pharmacology and Pharmacotherapy, University of Szeged, 6720 Szeged, Hungary.
  • Giricz Z; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Bencsik P; Department of Pharmacology and Pharmacotherapy, University of Szeged, 6720 Szeged, Hungary; Pharmahungary Group, 6722 Szeged, Hungary.
  • Varga ZV; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary; HCEMM-SU Cardiometabolic Immunology Research Group, 1089 Budapest, Hungary.
  • Novák J; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary; HCEMM-SU Cardiometabolic Immunology Research Group, 1089 Budapest, Hungary.
  • Helyes Z; Department of Pharmacology and Pharmacotherapy, Medical School & Szentágothai Research Centre, University of Pécs, 7624 Pécs, Hungary.
  • Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary; Pharmahungary Group, 6722 Szeged, Hungary.
  • Gyires K; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary.
  • Zádori ZS; Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1089 Budapest, Hungary. Electronic address: zadori.zoltan@med.semmelweis-univ.hu.
Biochem Pharmacol ; 178: 114099, 2020 08.
Article em En | MEDLINE | ID: mdl-32540483

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Cardiotônicos / Traumatismo por Reperfusão Miocárdica / Metaloproteinase 2 da Matriz / Ciclo-Oxigenase 2 / Inibidores de Ciclo-Oxigenase 2 / Intestino Delgado / Lactonas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Hungria País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonas / Cardiotônicos / Traumatismo por Reperfusão Miocárdica / Metaloproteinase 2 da Matriz / Ciclo-Oxigenase 2 / Inibidores de Ciclo-Oxigenase 2 / Intestino Delgado / Lactonas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Animals Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Hungria País de publicação: Reino Unido